This site provides INTERCEPT product information for Canada audiences. Visit Cerus.com for more information

Select Page

The INTERCEPT™ Blood System for Platelets and Plasma,
Pathogen Inactivation Process

CANADA Region

The INTERCEPT Blood System for Plasma and Platelets is approved in Canada

The INTERCEPT Blood System for plasma is intended to be used for the ex vivo preparation of pathogen-reduced, whole blood derived or apheresis plasma. The INTERCEPT Blood System for platelets is intended for the ex vivo treatment and storage of platelet components. The system is used to inactivate a broad range of pathogens, including viruses, bacteria, and protozoan parasites, thus reducing the risk of transfusion-transmitted infections (TTI).

Press Releases

Package Inserts

Contact Us

Phone: 1.855.835.3523
Email: customerservices.americas@cerus.com